Latest FDC stock price

FDC P/E Ratio

FDC • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
29.8
High Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 29.8
Current Price ₹400.00
EPS (TTM) ₹16.39
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 19.3
Historical Range 11.7 - 29.16
Percentile 100.0%

Sector Context

Sector Average 53.58
Sector Median 31.12
Sector Rank #11 of 131
Sector Percentile 8.4%

Earnings Breakdown (TTM)

TTM EPS ₹16.01
Sept 2025 ₹1.75
Mar 2025 ₹2.38

Key P/E Ratio Insights for FDC

  • Stock appears overvalued with PE of 29.8, suggesting caution for new investments
  • Current PE is 54.4% above historical average
  • Trading at discount to sector average PE of 53.58

View the FDC equity price for detailed stock performance.

P/E Ratio Historical Trend for FDC

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 23.38 16.86 ₹394.20 NSE Moderate
2023 15.68 17.55 ₹275.10 NSE Moderate
2022 29.16 10.4 ₹303.30 NSE High
2021 22.24 14.96 ₹332.75 NSE Moderate
2020 11.7 18.18 ₹212.75 NSE Low
2019 13.66 12.67 ₹173.05 NSE Low

Sector P/E Ratio Comparison

Comparing FDC with other companies in Healthcare sector
Sector Average
53.58
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.5 ₹51 Low
Ind Swift Laboratories INDSWFTLAB 3.18 ₹733 Low
Murae Organisor MURAE 3.86 ₹55 Low
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Zenith Drugs ZENITHDRUG 9.06 ₹84 Low
Galaxy Medicare GML 9.5 ₹32 Low
Balaxi Pharmaceuticals BALAXI 10.06 ₹139 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Vasundhara Rasayans VRL 11.3 ₹51 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low